{"id":"https://openalex.org/W3173661231","doi":"https://doi.org/10.1021/acs.molpharmaceut.1c00119","title":"Effect of Excipients on Salt Disproportionation during Dissolution: A Novel Application of In Situ Raman Imaging","display_name":"Effect of Excipients on Salt Disproportionation during Dissolution: A Novel Application of In Situ Raman Imaging","publication_year":2021,"publication_date":"2021-08-16","ids":{"openalex":"https://openalex.org/W3173661231","doi":"https://doi.org/10.1021/acs.molpharmaceut.1c00119","mag":"3173661231","pmid":"https://pubmed.ncbi.nlm.nih.gov/34399050"},"language":"en","primary_location":{"id":"doi:10.1021/acs.molpharmaceut.1c00119","doi":"https://doi.org/10.1021/acs.molpharmaceut.1c00119","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.1c00119","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1021/acs.molpharmaceut.1c00119","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016029834","display_name":"Amjad Abouselo","orcid":"https://orcid.org/0000-0002-6751-8467","observed_orcids":["https://orcid.org/0000-0002-6751-8467"]},"institutions":[{"id":"https://openalex.org/I142263535","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58","country_code":"GB","type":"education","lineage":["https://openalex.org/I142263535"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Amjad Abouselo","raw_affiliation_strings":["School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K"],"raw_orcid":"https://orcid.org/0000-0002-6751-8467","affiliations":[{"raw_affiliation_string":"School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K","institution_ids":["https://openalex.org/I142263535"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058037817","display_name":"Graham A. Rance","orcid":"https://orcid.org/0000-0002-8325-1096","observed_orcids":["https://orcid.org/0000-0002-8325-1096"]},"institutions":[{"id":"https://openalex.org/I142263535","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58","country_code":"GB","type":"education","lineage":["https://openalex.org/I142263535"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Graham A. Rance","raw_affiliation_strings":["School of Chemistry,\u00a0 Nanoscale and Microscale Reseach Centre, University of Nottingham, Nottingham NG7 2RD, U.K"],"raw_orcid":"https://orcid.org/0000-0002-8325-1096","affiliations":[{"raw_affiliation_string":"School of Chemistry,\u00a0 Nanoscale and Microscale Reseach Centre, University of Nottingham, Nottingham NG7 2RD, U.K","institution_ids":["https://openalex.org/I142263535"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039584149","display_name":"Francesco Tres","orcid":"https://orcid.org/0000-0001-6955-654X","observed_orcids":["https://orcid.org/0000-0001-6955-654X"]},"institutions":[{"id":"https://openalex.org/I219193219","display_name":"Purdue University West Lafayette","ror":"https://ror.org/02dqehb95","country_code":"US","type":"education","lineage":["https://openalex.org/I219193219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francesco Tres","raw_affiliation_strings":["Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 4790, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 4790, United States","institution_ids":["https://openalex.org/I219193219"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090835640","display_name":"Lynne S. Taylor","orcid":"https://orcid.org/0000-0002-4568-6021","observed_orcids":["https://orcid.org/0000-0002-4568-6021"]},"institutions":[{"id":"https://openalex.org/I219193219","display_name":"Purdue University West Lafayette","ror":"https://ror.org/02dqehb95","country_code":"US","type":"education","lineage":["https://openalex.org/I219193219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lynne S. Taylor","raw_affiliation_strings":["Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 4790, United States"],"raw_orcid":"https://orcid.org/0000-0002-4568-6021","affiliations":[{"raw_affiliation_string":"Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 4790, United States","institution_ids":["https://openalex.org/I219193219"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022049463","display_name":"Ana Kwokal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ana Kwokal","raw_affiliation_strings":["Platform Technology & Science, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Platform Technology & Science, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082283690","display_name":"L. Renou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ludovic Renou","raw_affiliation_strings":["Platform Technology & Science, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Platform Technology & Science, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023556737","display_name":"David J. Scurr","orcid":"https://orcid.org/0000-0003-0859-3886","observed_orcids":["https://orcid.org/0000-0003-0859-3886"]},"institutions":[{"id":"https://openalex.org/I142263535","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58","country_code":"GB","type":"education","lineage":["https://openalex.org/I142263535"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David J. Scurr","raw_affiliation_strings":["School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K"],"raw_orcid":"https://orcid.org/0000-0003-0859-3886","affiliations":[{"raw_affiliation_string":"School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K","institution_ids":["https://openalex.org/I142263535"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038180180","display_name":"J. Burley","orcid":"https://orcid.org/0000-0003-4030-1484","observed_orcids":["https://orcid.org/0000-0003-4030-1484"]},"institutions":[{"id":"https://openalex.org/I142263535","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58","country_code":"GB","type":"education","lineage":["https://openalex.org/I142263535"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Jonathan C. Burley","raw_affiliation_strings":["School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K","institution_ids":["https://openalex.org/I142263535"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071752588","display_name":"Jonathan W. Aylott","orcid":"https://orcid.org/0000-0003-1520-5490","observed_orcids":["https://orcid.org/0000-0003-1520-5490"]},"institutions":[{"id":"https://openalex.org/I142263535","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58","country_code":"GB","type":"education","lineage":["https://openalex.org/I142263535"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Jonathan W. Aylott","raw_affiliation_strings":["School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K"],"raw_orcid":"https://orcid.org/0000-0003-1520-5490","affiliations":[{"raw_affiliation_string":"School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K","institution_ids":["https://openalex.org/I142263535"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5038180180","https://openalex.org/A5071752588"],"corresponding_institution_ids":["https://openalex.org/I142263535"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":{"value":5000,"currency":"USD","value_usd":5000},"fwci":0.9116,"has_fulltext":true,"cited_by_count":19,"citation_normalized_percentile":{"value":0.6606028,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"18","issue":"9","first_page":"3247","last_page":"3259"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.6606000065803528,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.6606000065803528,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.21449999511241913,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.08860000222921371,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pioglitazone-hydrochloride","display_name":"pioglitazone hydrochloride","score":0.8970000147819519},{"id":"https://openalex.org/keywords/pharmaceutical-excipients","display_name":"pharmaceutical excipients","score":0.8019999861717224},{"id":"https://openalex.org/keywords/citric-acid-monohydrate","display_name":"citric acid monohydrate","score":0.8650000095367432},{"id":"https://openalex.org/keywords/lactose-monohydrate","display_name":"lactose monohydrate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/magnesium-stearate","display_name":"magnesium stearate","score":1.0},{"id":"https://openalex.org/keywords/confocal-raman-microscopy","display_name":"confocal Raman microscopy","score":0.9369999766349792},{"id":"https://openalex.org/keywords/dissolution-media-ph","display_name":"dissolution media pH","score":0.6520000100135803},{"id":"https://openalex.org/keywords/salt-stability","display_name":"salt stability","score":0.6449999809265137},{"id":"https://openalex.org/keywords/tablet-dissolution","display_name":"tablet dissolution","score":0.5139999985694885},{"id":"https://openalex.org/keywords/drug-release","display_name":"drug release","score":0.7120000123977661}],"concepts":[{"id":"https://openalex.org/C2777822432","wikidata":"https://www.wikidata.org/wiki/Q216681","display_name":"In situ","level":2,"score":0.8380863666534424},{"id":"https://openalex.org/C17365422","wikidata":"https://www.wikidata.org/wiki/Q664231","display_name":"Disproportionation","level":3,"score":0.7967606782913208},{"id":"https://openalex.org/C40003534","wikidata":"https://www.wikidata.org/wiki/Q862228","display_name":"Raman spectroscopy","level":2,"score":0.7698521614074707},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.7387701272964478},{"id":"https://openalex.org/C2776371256","wikidata":"https://www.wikidata.org/wiki/Q12370","display_name":"Salt (chemistry)","level":2,"score":0.6972367763519287},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5889216661453247},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.3264196813106537},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.15580132603645325},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.08663997054100037},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D005079","descriptor_name":"Excipients","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012492","descriptor_name":"Salts","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013059","descriptor_name":"Spectrum Analysis, Raman","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065546","descriptor_name":"Drug Liberation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1021/acs.molpharmaceut.1c00119","doi":"https://doi.org/10.1021/acs.molpharmaceut.1c00119","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.1c00119","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:34399050","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34399050","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:nottingham-repository.worktribe.com:5722686","doi":null,"is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.1c00119","pdf_url":null,"source":{"id":"https://openalex.org/S4306402483","display_name":"Repository@Nottingham (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Journal Article"},{"id":"pmh:oai:https://nottingham-repository.worktribe.com/:5722686","doi":null,"is_oa":true,"landing_page_url":"https://nottingham-repository.worktribe.com/output/5722686","pdf_url":"https://nottingham-repository.worktribe.com/file/5722686/1/Effect%20of%20Excipients%20on%20Salt","source":{"id":"https://openalex.org/S4306402483","display_name":"Repository@Nottingham (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1021/acs.molpharmaceut.1c00119","doi":"https://doi.org/10.1021/acs.molpharmaceut.1c00119","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.1c00119","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/6","score":0.6499999761581421,"display_name":"Clean water and sanitation"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1634381318","display_name":null,"funder_award_id":"EP\\\\L01646X","funder_id":"https://openalex.org/F4320334627","funder_display_name":"Engineering and Physical Sciences Research Council"}],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320320324","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58"},{"id":"https://openalex.org/F4320334627","display_name":"Engineering and Physical Sciences Research Council","ror":"https://ror.org/0439y7842"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W131007175","https://openalex.org/W309585134","https://openalex.org/W1022632952","https://openalex.org/W1561146211","https://openalex.org/W1580898924","https://openalex.org/W1965141081","https://openalex.org/W1967688016","https://openalex.org/W1967900999","https://openalex.org/W1968340770","https://openalex.org/W1982910731","https://openalex.org/W1990214726","https://openalex.org/W1994696430","https://openalex.org/W1997295165","https://openalex.org/W2009410249","https://openalex.org/W2013066396","https://openalex.org/W2026049752","https://openalex.org/W2036275323","https://openalex.org/W2037532625","https://openalex.org/W2039675557","https://openalex.org/W2044883409","https://openalex.org/W2052280371","https://openalex.org/W2075527407","https://openalex.org/W2082875971","https://openalex.org/W2083572003","https://openalex.org/W2084867636","https://openalex.org/W2085481328","https://openalex.org/W2092134018","https://openalex.org/W2097566449","https://openalex.org/W2099295435","https://openalex.org/W2100473852","https://openalex.org/W2106044278","https://openalex.org/W2118156024","https://openalex.org/W2139579029","https://openalex.org/W2174252676","https://openalex.org/W2326962754","https://openalex.org/W2335345240","https://openalex.org/W2509164087","https://openalex.org/W2566763285","https://openalex.org/W2574063315","https://openalex.org/W2583551047","https://openalex.org/W2589030761","https://openalex.org/W2626119202","https://openalex.org/W2804820400","https://openalex.org/W2916770640","https://openalex.org/W2952528349","https://openalex.org/W3009307834","https://openalex.org/W3017990117","https://openalex.org/W4235175490","https://openalex.org/W4252829828"],"related_works":["https://openalex.org/W2804820400","https://openalex.org/W2092134018","https://openalex.org/W1022632952","https://openalex.org/W2589030761","https://openalex.org/W4395069704","https://openalex.org/W2085481328","https://openalex.org/W2566763285","https://openalex.org/W2009410249","https://openalex.org/W4385294735","https://openalex.org/W2583551047"],"abstract_inverted_index":{"We":[0],"have":[1],"employed":[2],"a":[3,135,189],"bespoke":[4],"setup":[5],"combining":[6],"confocal":[7],"Raman":[8,179],"microscopy":[9],"and":[10,72,114,132,263],"an":[11,253],"ultraviolet-visible":[12],"(UV-Vis)":[13],"spectroscopy":[14,236],"flow":[15,248],"cell":[16,249],"to":[17,57,257,277],"investigate":[18,258],"the":[19,24,59,66,94,99,102,111,116,120,123,148,153,159,169,175,182,186,193,197,200,205,210,214,221,224,227,233,243,246,259,288],"effect":[20,137,260],"of":[21,27,38,61,68,98,101,119,168,181,188,192,199,207,209,223,245,261,281],"excipients":[22,85,262],"on":[23,65,138,220,266],"disproportionation":[25,70,91,146,268],"kinetics":[26,71],"Pioglitazone":[28],"HCl":[29],"(PioHCl)":[30],"in":[31,75,107,122,139,147,152,158,269],"tablets":[32,109,184],"during":[33,150],"dissolution.":[34],"Three":[35],"binary":[36],"formulations":[37],"PioHCl,":[39],"containing":[40],"citric":[41],"acid":[42],"monohydrate":[43,46],"(CA),":[44],"lactose":[45],"(LM),":[47],"or":[48,88],"magnesium":[49],"stearate":[50],"(MgSt),":[51],"respectively,":[52],"were":[53],"used":[54,276],"as":[55,230,252],"models":[56],"study":[58],"influence":[60],"excipients'":[62],"physicochemical":[63],"properties":[64],"rate":[67,206],"salt":[69,90,112,121,145,267,282],"dissolution":[73,103,117,151,176,211,264],"performance":[74,118,142],"different":[76],"aqueous":[77],"pH":[78,96,100],"environments.":[79],"It":[80],"was":[81],"found":[82],"that":[83,285],"formulation":[84],"can":[86],"induce":[87],"prevent":[89],"by":[92,143,232],"modulating":[93],"microenvironmental":[95],"regardless":[97],"media.":[104],"Incorporating":[105],"CA":[106],"PioHCl":[108],"preserves":[110],"form":[113],"enhances":[115],"acidic":[124,155],"medium":[125,161,212],"(pH":[126,162],"=":[127,163],"1.2).":[128],"In":[129],"contrast,":[130],"LM":[131],"MgSt":[133],"had":[134,217],"detrimental":[136],"vitro":[140],"drug":[141,237],"inducing":[144],"tablet":[149],"same":[154],"medium.":[156,177],"Dissolution":[157],"neutral":[160],"6.8)":[164],"showed":[165],"rapid":[166],"formation":[167,187],"free":[170,194],"base":[171,195],"upon":[172],"contact":[173],"with":[174],"The":[178],"maps":[180],"cross-sectioned":[183],"revealed":[185],"shell":[190,203],"consisting":[191],"around":[196],"edge":[198],"tablet.":[201],"This":[202,272],"decreased":[204],"penetration":[208],"into":[213,226],"tablet,":[215],"which":[216],"significant":[218],"implications":[219],"release":[222,238],"API":[225],"surrounding":[228],"solution,":[229],"shown":[231],"UV-vis":[234],"absorption":[235],"data.":[239],"Our":[240],"findings":[241],"highlight":[242],"utility":[244],"Raman/UV-vis":[247],"analytical":[250,255],"platform":[251],"advanced":[254],"technique":[256],"media":[265],"real":[270],"time.":[271],"methodology":[273],"will":[274],"be":[275],"enhance":[278],"our":[279],"understanding":[280],"stability":[283],"studies":[284],"may":[286],"pave":[287],"way":[289],"for":[290],"more":[291],"stable":[292],"multicomponent":[293],"formulations.":[294]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-07-05T00:00:00"}